Loading company…
Zoundream uses AI-based cry analysis to monitor infant health and identify potential developmental concerns.
Founded in 2019, Zoundream develops AI-based cry analysis technology for non-invasive monitoring of infants at home. Its system is designed to provide health insights for parents and pediatricians. Based in Basel, Switzerland, the company raised EUR 4 million in Seed funding in October 2025, led by CRB Inverbio with participation from other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in